Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Feb 11, 2025 · 10-Q · 42 days after period end · 0001520138-25-000056
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$7.11M | -$8.40M | -$15.69M | -$5.41M |
| EPS Diluted | -$4.55 | -$0.22 | -$0.50 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Feb 11, 2025 · 42 d after period end
